How does high-quality sequencing coverage impact the identification of diagnostic variants?
Exomes are increasingly becoming part of the diagnostic pathway for patients with inherited disorders. There are multiple aspects of exomes that can impact their ability to reach a diagnosis. This educational webinar will demonstrate how high-quality sequencing coverage can impact the identification of diagnostic variants. Cases will be presented which illustrate the diagnostic power of combining accurate whole exome sequencing with NGS-based copy number detection. Finally, different approaches to exome analysis will be compared and discussed with a focus on the advantages of a genotype-first approach.
- Explanation of quality and performance in whole exome sequencing
- Overview of NGS-based copy number detection and its significance in whole exome testing
- Description of the genotype-first approach to exome analysis and why it is an effective method for variant identification
Blueprint Academy is an educational resource for healthcare professionals and organizations, patients and the scientific community. We publish informative and empowering content, webinars and white papers from the world of genetics. #geneticknowledge
Dr Jennifer Schleit (PhD, FACMG) received a Bachelor of Science with Honours in Biochemistry and Microbiology from Dalhousie University and a PhD in Pathology from the University of Washington in Seattle, Washington, USA. She completed a clinical fellowship at the University of Washington and received her certification in clinical molecular genetics from the American Board of Medical Genetics and Genomics (ABMGG). Dr Schleit served as an Assistant Director at the Center for Precision Diagnostics at the University of Washington before accepting a position as Senior Geneticist at Blueprint Genetics in 2017. Currently, she is the Laboratory Director of the Seattle facility.